Page last updated: 2024-11-06

flusilazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Flusilazole is a systemic triazole fungicide with a broad spectrum of activity against a wide range of fungal diseases. It is effective in controlling diseases such as powdery mildew, rust, and leaf spot. Flusilazole is known for its ability to inhibit the biosynthesis of ergosterol, a key component of fungal cell membranes. This disruption of fungal cell membrane synthesis leads to cell death and the control of fungal infections. Flusilazole is widely used in agriculture to protect crops from fungal diseases, enhancing crop yields and reducing losses due to fungal infections. The study of flusilazole is ongoing to optimize its use, explore its potential in new applications, and understand its environmental impact.'

flusilazole: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

flusilazole : An organosilicon compound that is dimethylsilane in which the hydrogens attached to the silicon are replaced by p-fluorophenyl groups and a hydrogen attached to one of the methyl groups is replaced by a 1H-1,2,4-triazol-1-yl group. It is a broad-sepctrum fungicide used to protect a variety of crops. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID73675
CHEMBL ID1900522
CHEBI ID81922
SCHEMBL ID21313
MeSH IDM0170199

Synonyms (67)

Synonym
LS-14474
flusilazole, analytical standard
NCGC00164304-01
flusilazol
bis(4-fluorophenyl)methyl(1h-1,2,4-triazol-1-ylmethyl)silane
flusilazole [iso]
dpx-h 6573
caswell no. 419k
olymp
1h-1,2,4-triazole, 1-((bis(4-fluorophenyl)methylsilyl)methyl)-
fluzilazol
dpx 6573
punch
brn 5824097
epa pesticide chemical code 128835
sanction
1-((bis(4-fluorophenyl)methylsilyl)methyl)-1h-1,2,4-triazole
flusilazole
nustar
1-[[bis(4-fluorophenyl)methylsilyl]methyl]-1h-1,2,4-triazole ,
85509-19-9
NCGC00164304-02
dpx-h6573
bis(4-fluorophenyl)-methyl-(1,2,4-triazol-1-ylmethyl)silane
FT-0652761
NCGC00164304-03
NCGC00164304-04
C18733
dtxsid3024235 ,
tox21_300761
tox21_201484
NCGC00259035-01
dtxcid704235
NCGC00254665-01
cas-85509-19-9
chebi:81922 ,
CHEMBL1900522
unii-f3wg2vvd87
f3wg2vvd87 ,
punch 40ec
dpd 78710f
AKOS015907679
flusilazole [mi]
bis(4-fluorophenyl)(methyl)(1h-1,2,4-triazol-1-ylmethyl)silane
SCHEMBL21313
1-{[bis(4-fluorophenyl)(methyl)silyl]methyl}-1h-1,2,4-triazole
di(4-fluorophenyl)(1,2,4-triazole-2-ylmethyl)methylsilane
1-[[bis(4-fluorophenyl)methylsilyl]methyl]-1h-1,2,4- triazole
1h-1,2,4-triazole, 1-[[bis(4-fluorophenyl)methylsilyl]methyl]-
1-([bis(4-fluorophenyl)(methyl)silyl]methyl)-1h-1,2,4-triazole
flusilazole, pestanal(r), analytical standard
punch (pesticide)
flusilazole 10 microg/ml in acetonitrile
flusilazole 100 microg/ml in ethyl acetate
ppx-h6573
dpx-n6573
1-[[bis(4-fluorophenyl)methylsilyl]methyl]-1h-1,2,4-triazole, 9ci
1-((bis(4-fluorophenyl)(methyl)silyl)methyl)-1h-1,2,4-triazole
Q499791
HY-B2012
AMY22445
CS-0014113
dpx6573
dpx-6573
E79438
flusilazole 1000 microg/ml in acetone
flusilazole 1000 microg/ml in toluene

Research Excerpts

Overview

Flusilazole is an organosilane fungicide used for treatments in agriculture and horticulture.

ExcerptReferenceRelevance
"Flusilazole is an organosilane fungicide used for treatments in agriculture and horticulture for control of diseases. "( Reaction kinetics and mechanisms of organosilicon fungicide flusilazole with sulfate and hydroxyl radicals.
Arques, A; Bracco, LLB; Caregnato, P; Gonzalez, MC; Mercado, DF, 2018
)
2.17

Bioavailability

ExcerptReferenceRelevance
" However, data on their environmental behaviour and bioavailability to soil organisms are surprisingly scarce."( Ageing effect on conazole fungicide bioaccumulation in arable soils.
Bílková, Z; Hofman, J; Peštálová, N; Sedláček, P; Šudoma, M, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" The results of residual dynamics experiment showed that after the apple was treated by flusilazole at treble of recommended high dosage (3."( Residue and dissipation dynamics of flusilazole in apple and soil.
Guo, X; Han, L; Jiang, S; Qin, D; Wu, Q; Yu, S, 2011
)
0.87
" For developmental toxicity this requires scaling the in vitro observed dose-response characteristics to in vivo fetal exposure, while integrating maternal in vivo kinetics during pregnancy, in particular transplacental transfer."( Integrating in vitro chemical transplacental passage into a generic PBK model: A QIVIVE approach.
Fragki, S; Hoogenveen, R; Piersma, AH; Schwillens, P; van Oostrom, C; Zeilmaker, MJ, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitorAn EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor that interferes with the action of EC 1.14.13.70 (sterol 14alpha-demethylase).
antifungal agrochemicalAny substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
monofluorobenzenesAny member of the class of fluorobenzenes containing a mono- or poly-substituted benzene ring carrying a single fluorine substitutent.
triazolesAn azole in which the five-membered heterocyclic aromatic skeleton contains three N atoms and two C atoms.
organosilicon compoundAn organosilicon compound is a compound containing at least one carbon-silicon bond.
conazole fungicideAny conazole antifungal agent that has been used as a fungicide.
triazole fungicideAny triazole antifungal agent that has been used as a fungicide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (30)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency89.35840.007215.758889.3584AID1224835
pregnane X receptorRattus norvegicus (Norway rat)Potency11.22020.025127.9203501.1870AID651751
RAR-related orphan receptor gammaMus musculus (house mouse)Potency37.01490.006038.004119,952.5996AID1159521; AID1159523
SMAD family member 2Homo sapiens (human)Potency3.88950.173734.304761.8120AID1346859
SMAD family member 3Homo sapiens (human)Potency3.88950.173734.304761.8120AID1346859
GLI family zinc finger 3Homo sapiens (human)Potency14.17280.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency39.16090.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743036; AID743042; AID743054; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency63.12530.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency45.76470.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency10.49060.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency38.13770.000214.376460.0339AID720691; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency60.73470.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency27.29610.000817.505159.3239AID1159527; AID1159531; AID588544; AID588546
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency35.02350.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency31.31860.375827.485161.6524AID588526; AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency18.31210.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency55.60240.000229.305416,493.5996AID1259244; AID1259248; AID743069; AID743075; AID743078; AID743079; AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency54.61570.001024.504861.6448AID588534; AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency54.94100.001019.414170.9645AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency31.08170.023723.228263.5986AID743222; AID743223
aryl hydrocarbon receptorHomo sapiens (human)Potency21.68990.000723.06741,258.9301AID743085
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency0.43060.001723.839378.1014AID743083
activating transcription factor 6Homo sapiens (human)Potency56.77440.143427.612159.8106AID1159516
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency63.701919.739145.978464.9432AID1159509
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency41.03770.000323.4451159.6830AID743065; AID743066; AID743067
heat shock protein beta-1Homo sapiens (human)Potency54.94100.042027.378961.6448AID743210
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency76.95880.000627.21521,122.0200AID743202
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency47.15600.001557.789015,848.9004AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency71.15960.002319.595674.0614AID651631; AID720552
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency47.15600.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (124)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (20)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (61)

Assay IDTitleYearJournalArticle
AID1112240Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as pathogen incidence at 4 g AI /100 L applied 24 hr prior inoculation to pruning wound measured after 3 months2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1111318Antifungal activity against Leptosphaeria maculans assessed as viable ascospore at 0.25 to 1 ug/ml after 1 week2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1112872Resistance index, ratio of EC50 for prochloraz-resistant Oculimacula yallundae isolate ProR1 to EC50 for prochloraz-susceptible Oculimacula yallundae isolate ProS by germ tube elongation inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112268Fungicidal activity against Neofusicoccum luteum G(s)-1 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112226Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as mean pathogen compound applied 24 hr prior inoculation to pruning wound measured after 1 year2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1111334Antifungal activity against Leptosphaeria maculans assessed as reduction of germ tube length at 0.25 ug/ml after 22 hr relative to control2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1112263Fungicidal activity against Diplodia mutila Q assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112230Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as pathogen incidence at dieback edges compound applied 24 hr prior inoculation to pruning wound measured after 1 year2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1111343Antifungal activity against Leptosphaeria biglobosa assessed as ascospore germination at 0.25 to 1 ug/ml after 22 hr2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1111326Antifungal activity against Leptosphaeria biglobosa assessed as reduction of germ tube length at 0.25 ug/ml after 22 hr relative to control2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1112888Fungicidal activity against Oculimacula yallundae assessed as inhibition of mycelial growth in presence of 10 g glucose incubated at 19 degC in dark for 4 weeks2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1111309Antifungal activity against Leptosphaeria maculans assessed as reduction of conidia production at 0.25 to 1 ug/ml after 2 weeks2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1112257Fungicidal activity against Neofusicoccum luteum N(12)2 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112876Fungicidal activity against prochloraz-susceptible Oculimacula yallundae isolate ProS assessed as inhibition of mycelial growth in presence of 10 g glucose incubated at 19 degC in dark for 4 weeks2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112255Fungicidal activity against Diplodia mutila F (12)2 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112260Fungicidal activity against Neofusicoccum australe J-3 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1111298Antifungal activity against Leptosphaeria maculans assessed as ascospore germination at 0.25 to 1 ug/ml after 22 hr2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1112271Fungicidal activity against Neofusicoccum australe Kat-1 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1111305Antifungal activity against Leptosphaeria biglobosa assessed as viable conidia at 0.25 to 1 ug/ml after 1 week2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1112259Fungicidal activity against Neofusicoccum luteum G(s)-1 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1111339Antifungal activity against Leptosphaeria biglobosa assessed as inhibition of conidia germination at 0.25 to 1 ug/ml after 22 hr2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1111306Antifungal activity against Leptosphaeria maculans assessed as viable conidia at 0.25 to 1 ug/ml after 1 week2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1111332Antifungal activity against Leptosphaeria maculans assessed as reduction of germ tube length at 1 ug/ml after 22 hr relative to control2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1112892Fungicidal activity against Oculimacula acuformis assessed as inhibition of germ tube elongation incubated at 19 degC in dark for 48 hr2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1082463In vivo antifungal activity against Puccinia recondita infected wheat seedlings assessed as reduction in wheat leaf rust disease symptoms development at 2 ug/ml treated 1 day before spore inoculation measured 7 days after inoculation2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Nematicidal and antifungal activities of annonaceous acetogenins from Annona squamosa against various plant pathogens.
AID1112875Fungicidal activity against prochloraz-susceptible Oculimacula yallundae isolate ProS assessed as inhibition of germ tube elongation incubated at 19 degC in dark for 48 hr2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112891Fungicidal activity against Oculimacula yallundae assessed as inhibition of germ tube elongation incubated at 19 degC in dark for 48 hr2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112887Selectivity index, ratio of EC50 for Oculimacula acuformis to EC50 for Oculimacula yallundae in presence of 10 g glucose by mycelial growth inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1082464In vivo antifungal activity against Puccinia recondita infected wheat seedlings assessed as reduction in wheat leaf rust disease symptoms development at 10 ug/ml treated 1 day before spore inoculation measured 7 days after inoculation2011Journal of agricultural and food chemistry, Oct-26, Volume: 59, Issue:20
Nematicidal and antifungal activities of annonaceous acetogenins from Annona squamosa against various plant pathogens.
AID1111312Antifungal activity against Leptosphaeria biglobosa assessed as reduction of conidia production at 0.25 to 1 ug/ml after 2 weeks2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1112229Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as non-lesion areas compound applied 24 hr prior inoculation to pruning wound measured after 1 year2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112264Fungicidal activity against Diplodia mutila Iso-2 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112254Fungicidal activity against Diplodia mutila Q assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1111299Antifungal activity against Leptosphaeria biglobosa assessed as inhibition of mycelial growth after 7 days2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1111340Antifungal activity against Leptosphaeria maculans assessed as inhibition of conidia germination at 0.25 to 1 ug/ml after 22 hr2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1113131Fungicidal activity against Oculimacula yallundae inoculated in 24 hr compound-treated plant foliage assessed as disease control at 20 ppm measured after 7 days1995Pharmaceutica acta Helvetiae, Dec, Volume: 70, Issue:4
Synthesis and fungicide activity of 2,3-dihydroimidazo [2,1-b]thiazole-5-carboxamides.
AID1112874Resistance index, ratio of EC50 for prochloraz-resistant Oculimacula yallundae isolate ProR1 to EC50 for prochloraz-susceptible Oculimacula yallundae isolate ProS by mycelial growth inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112228Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as pathogen incidence at closest side shoot compound applied 24 hr prior inoculation to pruning wound measured after 6 months2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112265Fungicidal activity against Diplodia mutila F (12)2 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112227Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as pathogen incidence at area beyond node compound applied 24 hr prior inoculation to pruning wound measured after 1 year2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1111300Antifungal activity against Leptosphaeria maculans assessed as inhibition of mycelial growth after 17 days2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1111324Antifungal activity against Leptosphaeria biglobosa assessed as reduction of germ tube length at 1 ug/ml after 22 hr relative to control2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1083141Fungicidal activity against Cladosporium cucumerinum infected drug-pretreated cucumber two seeded leaves assessed as decrease in disease index at 40% SC formulation (acetone Rvb = 3.18 +/-0.75%)2012Journal of agricultural and food chemistry, Nov-28, Volume: 60, Issue:47
Synthesis and fungicidal activity of novel 2,5-disubstituted-1,3,4-oxadiazole derivatives.
AID1112871Resistance index, ratio of EC50 for prochloraz-resistant Oculimacula yallundae isolate ProR2 to EC50 for prochloraz-susceptible Oculimacula yallundae isolate ProS by germ tube elongation inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112889Fungicidal activity against Oculimacula acuformis assessed as inhibition of mycelial growth in presence of 10 g glucose incubated at 19 degC in dark for 4 weeks2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1111317Antifungal activity against Leptosphaeria biglobosa assessed as viable ascospore at 0.25 to 1 ug/ml after 1 week2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1112890Selectivity index, ratio of EC50 for Oculimacula acuformis to EC50 for Oculimacula yallundae by germ tube elongation inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112258Fungicidal activity against Neofusicoccum luteum M (13)8 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112873Resistance index, ratio of EC50 for prochloraz-resistant Oculimacula yallundae isolate ProR2 to EC50 for prochloraz-susceptible Oculimacula yallundae isolate ProS by mycelial growth inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112261Fungicidal activity against Neofusicoccum australe Mel-2 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112266Fungicidal activity against Neofusicoccum luteum M (13)8 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112256Fungicidal activity against Diplodia mutila Iso-2 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1113130Fungicidal activity against Phaeosphaeria nodorum inoculated in 24 hr compound-treated plant foliage assessed as disease control at 20 ppm measured after 7 days1995Pharmaceutica acta Helvetiae, Dec, Volume: 70, Issue:4
Synthesis and fungicide activity of 2,3-dihydroimidazo [2,1-b]thiazole-5-carboxamides.
AID1112270Fungicidal activity against Neofusicoccum australe Mel-2 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112262Fungicidal activity against Neofusicoccum australe Kat-1 assessed as conidial germination inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112269Fungicidal activity against Neofusicoccum australe J-3 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1111325Antifungal activity against Leptosphaeria biglobosa assessed as reduction of germ tube length at 0.5 ug/ml after 22 hr relative to control2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1111333Antifungal activity against Leptosphaeria maculans assessed as reduction of germ tube length at 0.5 ug/ml after 22 hr relative to control2010Pest management science, Apr, Volume: 66, Issue:4
Effects of fungicides on in vitro spore germination and mycelial growth of the phytopathogens Leptosphaeria maculans and L. biglobosa (phoma stem canker of oilseed rape).
AID1112251Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as dieback lesion length at 4 g AI /100 L applied 24 hr prior inoculation to pruning wound measured after 3 months2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112267Fungicidal activity against Neofusicoccum luteum N(12)2 assessed as mycelial growth inhibition after 48 hr2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
AID1112231Fungicidal activity against Neofusicoccum luteum infected Pinot noir grapevine assessed as pathogen incidence at dieback sites compound applied 24 hr prior inoculation to pruning wound measured after 1 year2012Pest management science, May, Volume: 68, Issue:5
Evaluation of fungicides for the management of Botryosphaeria dieback diseases of grapevines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (51)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.96)18.7374
1990's4 (7.84)18.2507
2000's2 (3.92)29.6817
2010's29 (56.86)24.3611
2020's15 (29.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.73 (24.57)
Research Supply Index3.97 (2.92)
Research Growth Index5.74 (4.65)
Search Engine Demand Index68.78 (26.88)
Search Engine Supply Index2.90 (0.95)

This Compound (36.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (5.77%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other49 (94.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]